Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CISECON: Conversion to Once-Daily Immunosuppression in Kidney Transplant
NCT01964014Phase 4Completed
- Sponsor
- Ajou University School of Medicine
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Modality
- RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tacrolimus in kidney transplant rejection, sponsored by Ajou University School of Medicine. Started Oct 2013; status: completed.
02
Drugs
tacrolimus
03
Conditions
kidney transplant rejection
Beyond the preview
Go deeper on NCT01964014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01964014.